Appointments at PharmaNet, Synexus, KCAS, Catalent and CIS – People on the move

By Nick Taylor

- Last updated on GMT

Related tags: Executive director, Clinical trial, Synexus

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PharmaNet, Synexus, KCAS, Catalent and CIS.

PharmaNet Development Group ​has strengthened its Phase IV development team by making three appointments. Firstly, Ron Weishaar​ has been named executive director of observational research. Weishaar has previously worked at Omnicare Clinical Research and Warner-Lambert.

Mike Nelson ​has also joined the company as executive director of health economics and outcomes research. Earlier in his career Nelson held positions at Covance and i3 Innovus.

Finally, Ken Ashman ​has been appointed as executive director of European operations. Ashman has also worked at Covance, PRA, Icon, ClinTrials and Quintiles.

Masood Khan ​has joined KCAS​ as senior director of ligand binding assay (LBA) services. Khan has previously worked at MDS, Covance, NeuroBiotech and MedImmune.

Synexus ​has appointed two new country managers. Helena Sigal ​joined Synexus when it acquired ClinPharm in 2009 and has now been appointed as country manager for Germany.

The contract research organisation (CRO) also named Radoslaw Janiak​ as country manager for Poland. Janiak joined Synexus in 2004 as the clinical site director for Poland.

Catalent Pharma Solutions ​has appointed Barry Russell​ as group president, commercial packaging. Russell joins from Ferro and during his career has also worked at Matson-CFM Technologies and FMC.

Lisa McNair ​has joined Compliance Implementation Services ​(CIS) as senior manager of Tricare Contracting. McNair has previously worked at the US Department of Defense.

D2 Pharma Consulting ​has hired Rena Goins ​as senior director, speciality markets. Goins has 20 years of distribution and speciality expertise at companies including PRN Services, Cardinal Health and McKesson Speciality Care Solutions.

Related topics: Markets & Regulations

Related news

Show more

Follow us


View more